Relationship between cardio-ankle vascular index and N-terminal pro-brain natriuretic peptide in hypertension and coronary heart disease subjects

被引:6
作者
Wang, Hongyu [1 ]
Liu, Jinbo [1 ]
Zhao, Hongwei [1 ]
Zhou, Yingyan [1 ]
Zhao, Xujing [1 ]
Song, Yuejie [1 ]
Li, Lihong [1 ]
Shi, Hongyan [1 ]
机构
[1] Peking Univ, Shougang Hosp, Dept Vasc Med, Beijing 100144, Peoples R China
关键词
Arterial stiffness; Biomarkers; PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; COMMUNITY; FAILURE; CAVI; ATHEROSCLEROSIS; POPULATION; BIOMARKERS; MORTALITY;
D O I
10.1016/j.jash.2014.05.009
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Arterial stiffness is an independent predictor for vascular diseases. Cardio-ankle vascular index (CAVI) is a new index of arterial stiffness. N-terminal pro-brain natriuretic peptide (NT-proBNP) is a strong prognostic marker in advanced stage of coronary heart disease (CHD). In the present study, we investigated the relationship between CAVI and NT-proBNP in hypertension and CHD subjects. Five hundred one subjects (male/female, 209/292) from Vascular Medicine of Peking University Shougang Hospital were divided into four groups: healthy group (n = 186), hypertension group (n = 159), CHD group (n = 45), and hypertension with CHD group (n = 111). CAVI was measured using VS-1000 apparatus. Our results showed that CAVI was significantly higher in hypertension subjects with CHD than in healthy and hypertension group, respectively (8.42 +/- 1.51 vs. 7.77 +/- 1.19; 8.42 +/- 1.51 vs. 7.92 +/- 1.11; both P <.05). NT-proBNP was significantly higher in hypertension subjects with CHD than in healthy, hypertension, and CHD group, respectively (422.48 +/- 761.60 vs. 174.29 +/- 415.48; 422.48 +/- 761.60 vs. 196.14 +/- 299.16; 422.48 +/- 761.60 vs. 209.66 +/- 242.66; all P <.05). And after log transformation of NT-proBNP, this phenomenon also exists (2.32 +/- 0.47 vs. 2.03 +/- 0.40; 2.32 +/- 0.47 vs. 2.09 +/- 0.44; 2.32 +/- 0.47 vs. 2.12 +/- 0.42; all P <.05). There was positive correlation between log NT-proBNP and CAVI in the entire study group, healthy group, and nonhealthy group (r = 0.235, P <.001; r = 0.184, P =.023; r = 0.237, P <.001; respectively). Multivariate analysis showed that NT-proBNP was an independent associating factor of CAVI in all subjects (beta=0.150, P =.021). Our present study showed that CAVI and NT-proBNP were significantly higher in hypertension subjects with CHD compared with healthy and hypertension groups. There was significant correlation between NT-proBNP and CAVI, which indicates the relationship between arterial stiffness and biomarkers in vascular-related diseases. Crown Copyright (C) 2014 Published by Elsevier Inc. on behalf of American Society of Hypertension. All rights reserved.
引用
收藏
页码:637 / 643
页数:7
相关论文
共 50 条
  • [41] N-Terminal Pro-Brain Natriuretic Peptide Correlates with Ghrelin and Acyl-Ghrelin in Pre-Dialysis Chronic Kidney Disease
    Rusu, Crina Claudia
    Anton, Florin
    Valea, Ana
    Bondor, Cosmina Ioana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [42] Prediction of Heart Function and Volume Status in End-Stage Kidney Disease Patients through N-Terminal Pro-Brain Natriuretic Peptide
    Lee, Kyung Ho
    Moon, Inki
    Oh, Young Seung
    Yu, Byung Chul
    Park, Moo Yong
    Kim, Jin Kuk
    Choi, Soo Jeong
    MEDICINA-LITHUANIA, 2022, 58 (08):
  • [43] Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease
    Zachariah, Justin P.
    Aliku, Twalib
    Scheel, Amy
    Hasan, Babar S.
    Lwabi, Peter
    Sable, Craig
    Beaton, Andrea Z.
    ANNALS OF PEDIATRIC CARDIOLOGY, 2016, 9 (02) : 120 - 125
  • [44] Diagnosis of chronic heart failure by the soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide
    Jin, Xiao-Ling
    Huang, Ning
    Shang, Hui
    Zhou, Ming-Cheng
    Hong, Yi
    Cai, Wen-Zheng
    Huang, Jie
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (03)
  • [45] N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity The Atherosclerosis Risk in Communities (ARIC) Study
    Ndumele, Chiadi E.
    Matsushita, Kunihiro
    Sang, Yingying
    Lazo, Mariana
    Agarwal, Sunil K.
    Nambi, Vijay
    Deswal, Anita
    Blumenthal, Roger S.
    Ballantyne, Christie M.
    Coresh, Josef
    Selvin, Elizabeth
    CIRCULATION, 2016, 133 (07) : 631 - 638
  • [46] Relationship between cardio-ankle vascular index and coronary artery calcification in a population sample of southwestern Siberia
    Sumin, Aleksei N.
    Shcheglova, Anna, V
    Kokov, Aleksandr N.
    Kachurina, Elena N.
    Barbarash, Olga L.
    RUSSIAN OPEN MEDICAL JOURNAL, 2022, 11 (04)
  • [47] A multiplexed point-of-care assay for C-reactive protein and N-terminal pro-brain natriuretic peptide
    Melin, Jonas
    Rundstrom, Gerd
    Peterson, Christer
    Bakker, Jimmy
    MacCraith, Brian D.
    Read, Mike
    Ohman, Ove
    Jonsson, Christina
    ANALYTICAL BIOCHEMISTRY, 2011, 409 (01) : 7 - 13
  • [48] N-Terminal Pro-Brain Natriuretic Peptide and Risk of Cardiovascular Events in a Japanese Community The Hisayama Study
    Doi, Yasufumi
    Ninomiya, Toshiharu
    Hata, Jun
    Hirakawa, Yoichiro
    Mukai, Naoko
    Ikeda, Fumie
    Fukuhara, Masayo
    Iwase, Masanori
    Kiyohara, Yutaka
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (12) : 2997 - 3003
  • [49] Nighttime home blood pressure as a mediator of N-terminal pro-brain natriuretic peptide in cardiovascular events
    Hoshide, Satoshi
    Kanegae, Hiroshi
    Kario, Kazuomi
    HYPERTENSION RESEARCH, 2021, 44 (09) : 1138 - 1146
  • [50] Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
    Liu, Pang-Yen
    Lin, Chin
    Lin, Chin-Sheng
    Fang, Wen-Hui
    Lee, Chia-Cheng
    Wang, Chih-Hung
    Tsai, Dung-Jang
    DIAGNOSTICS, 2023, 13 (17)